DGX
Quest Diagnostics Incorporated · Healthcare · Medical - Diagnostics & Research
Momentum-inputs (vergelijkbare managers):
breedte van houders +15.4% ·
aandelenstroom -3.1% ·
netto nieuwe posities +13.3%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 155 | +1 | 78.04M | $16.53B | +7 | −5 |
| Q1 2026 | 156 | -1 | 76.50M | $14.98B | +4 | −6 |
| Q4 2025 | 156 | +4 | 87.42M | $15.15B | +5 | — |
| Q3 2025 | 16 | -1 | 54.97M | $10.47B | — | −2 |
| Q2 2025 | 15 | -3 | 44.54M | $8.00B | — | −3 |
| Q1 2025 | 15 | +2 | 17.80M | $3.01B | +3 | −1 |
| Q4 2024 | 13 | -2 | 18.37M | $2.77B | — | −2 |
| Q3 2024 | 14 | -1 | 12.70M | $1.97B | — | −1 |
| Q2 2024 | 15 | — | 9.75M | $1.33B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 5.98M | +9.0% | $1.01B | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 5.98M | +9.0% | $1.01B | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passief) | 5.18M | -0.8% | $875.92M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 2.77M | +3.1% | $467.86M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passief) | 2.77M | +3.1% | $467.86M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.76M | -1.4% | $297.50M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.76M | -1.4% | $297.50M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.76M | -1.4% | $297.50M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.76M | -1.4% | $297.50M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 10 | Wellington Management ✦ | 1.76M | -1.4% | $297.50M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 1.76M | -1.4% | $297.50M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 12 | Norges Bank ✦ (passief) | 1.29M | +1.4% | $218.17M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Marshall Wace ✦ | 483.29K | -39.3% | $81.77M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 14 | Marshall Wace ✦ | 483.29K | -39.3% | $81.77M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 136.04K | Nieuw | $23.02M | 0.0% | New | 1 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 72.62K | -62.6% | $12.29M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 54.65K | -62.7% | $9.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 54.65K | -62.7% | $9.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 54.65K | -62.7% | $9.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 54.65K | -62.7% | $9.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 29.27K | +33.7% | $4.95M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | Millennium Management ✦ | 15.28K | -97.7% | $2.58M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 10.54K | -51.9% | $1.78M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 9.28K | +592.3% | $1.57M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 25 | Arrowstreet Capital ✦ | 7.96K | Nieuw | $1.35M | 0.0% | New | 1 | SEC ↗ |
| 26 | Fisher Asset Management ✦ | 2.35K | Nieuw | $397,388 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Citadel Advisors | $23.02M | 0.0% |
| Arrowstreet Capital | $1.35M | 0.0% |
| Fisher Asset Management | $397,388 | 0.0% |
Verlaten
| D. E. Shaw & Co. | $11.97M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 41.40K aandelen, $8,113 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.